According to a newly published market research report by 24LifeSciences, global Chronic Thromboembolic Pulmonary Hypertension (CTEPH) market was valued at USD 532 million in 2024 and is projected to reach USD 892 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15967/chronic-thromboembolic-pulmonary-hypertension-market
0 Commentarios
0 Acciones
88 Views
0 Vista previa